LLMpediaThe first transparent, open encyclopedia generated by LLMs

United States ex rel. Herbert v. National Institute of Health

Generated by DeepSeek V3.2
Note: This article was automatically generated by a large language model (LLM) from purely parametric knowledge (no retrieval). It may contain inaccuracies or hallucinations. This encyclopedia is part of a research project currently under review.
Article Genealogy
Parent: Avastin Hop 4
Expansion Funnel Raw 35 → Dedup 0 → NER 0 → Enqueued 0
1. Extracted35
2. After dedup0 (None)
3. After NER0 ()
4. Enqueued0 ()
United States ex rel. Herbert v. National Institute of Health
NameUnited States ex rel. Herbert v. National Institute of Health
CourtUnited States Court of Appeals for the Fourth Circuit
Date decidedMarch 2, 2004
Full nameUnited States ex rel. Herbert v. National Institute of Health, et al.
Citations357 F.3d 441
JudgesJ. Harvie Wilkinson III, M. Blane Michael, Robert B. King
Prior actionsDismissed by the United States District Court for the District of Maryland
Subsequent actionsNone
KeywordsFalse Claims Act, qui tam, public disclosure bar, National Institutes of Health

United States ex rel. Herbert v. National Institute of Health was a significant qui tam lawsuit filed under the False Claims Act against the National Institutes of Health and several affiliated researchers. The case, decided by the United States Court of Appeals for the Fourth Circuit in 2004, centered on allegations of fraudulent grant applications and the critical interpretation of the Act's "public disclosure bar." The ruling clarified the jurisdictional boundaries for whistleblower suits, reinforcing that allegations based primarily on publicly available information, without direct insider knowledge, are statutorily barred.

The lawsuit emerged from the complex framework of federal research funding administered by agencies like the National Institutes of Health. During the 1990s, the False Claims Act was a potent tool for the United States Department of Justice and private whistleblowers, known as relators, to combat fraud against the Federal government of the United States. The Act includes a "public disclosure bar" designed to prevent parasitic lawsuits by individuals who simply repackage information already in the public domain through sources like Congressional hearings, GAO reports, or the news media. This legal provision was central to the dispute in Herbert, as the relator, Dr. Robert Herbert, was a former employee of the National Institute of Mental Health.

Allegations and qui tam provisions

The relator, Dr. Robert Herbert, alleged that several senior scientists, including Dr. David R. Sibley and Dr. Ian Creese, along with their institutions such as the Johns Hopkins University and the University of Pennsylvania, submitted fraudulent applications for National Institutes of Health research grants. The claims specifically involved assertions that the researchers falsified data and misrepresented their preliminary findings to secure funding from the National Institute of Neurological Disorders and Stroke. Herbert filed his complaint under the qui tam provisions of the False Claims Act, which allow private citizens to sue on behalf of the United States government and share in any recovery. However, the United States Department of Justice declined to intervene in the case, leaving Herbert to pursue the litigation privately.

District court proceedings

The United States District Court for the District of Maryland, presided over by Judge Alexander Williams Jr., dismissed Herbert's lawsuit. The court's decision hinged on the application of the public disclosure bar. Judge Williams found that the core allegations of fraud had already been publicly disclosed through prior administrative proceedings and extensive correspondence involving the Office of Research Integrity at the Department of Health and Human Services. Because Herbert was not an "original source" of the information—defined as someone with direct and independent knowledge—the court held it lacked jurisdiction under the False Claims Act. This dismissal prompted Herbert's appeal to the United States Court of Appeals for the Fourth Circuit.

Appeals court ruling

On March 2, 2004, a panel of the United States Court of Appeals for the Fourth Circuit affirmed the district court's dismissal. The opinion, authored by Judge J. Harvie Wilkinson III and joined by Judges M. Blane Michael and Robert B. King, meticulously analyzed the public disclosure bar. The court ruled that the allegations had indeed been publicly disclosed through the administrative proceedings and investigations conducted by the Office of Research Integrity. The judges concluded that Herbert's complaint was substantially based upon these prior public disclosures, not on his own direct knowledge. Therefore, he did not qualify as an original source, and the False Claims Act barred the suit. The decision reinforced a strict interpretation of the jurisdictional limits intended by Congress.

Significance and impact

The Herbert decision had a substantial impact on the landscape of qui tam litigation, particularly within the Fourth Circuit and for cases involving scientific research fraud. It served as a clarifying precedent for the application of the public disclosure bar, emphasizing that whistleblowers must possess genuine, unmediated knowledge of the fraud, not merely derivative awareness from government reports or news media. The ruling was cited in subsequent key decisions, such as United States ex rel. Ondis v. City of Woonsocket, and influenced how relators and their counsel structure complaints. Furthermore, it underscored the challenges of pursuing False Claims Act cases in the context of academic science and complex federal grant administration, shaping legal strategies for both plaintiffs and defendants in research misconduct allegations.

Category:United States False Claims Act case law Category:2004 in United States case law Category:United States Court of Appeals for the Fourth Circuit cases Category:National Institutes of Health